Rankings / Mood, Anxiety & Stress

Buspirone

Mood, Anxiety & Stress · 5-HT1A partial agonist

Tier B+

prescription
7.1 / 10
Tier B+
Ev 6 Bn 5 Sf 9

Bottom line

Read Off Label grades Buspirone as B+ (7.1/10) based on moderate evidence, moderate benefit magnitude, and a low-risk safety profile.

Overshadowed by benzodiazepines and SSRIs but a legitimate non-addictive, non-sedating anxiolytic for chronic GAD.

Typical use: 15-60 mg/day PO divided (2-3x/day) — Rx.

What this is

Overshadowed by benzodiazepines and SSRIs but a legitimate non-addictive, non-sedating anxiolytic for chronic GAD. Slow onset frustrates patients expecting benzodiazepine-speed effects. Often combined with SSRIs as augmentation.

Mechanism

Partial agonist at 5-HT1A receptors; weak D2 antagonist; no sedation, no tolerance, no addiction potential unlike benzodiazepines; used for chronic GAD

Dose & route

15-60 mg/day PO divided (2-3x/day)

Common questions

Does Buspirone work?
Read Off Label rates the evidence for Buspirone as Moderate and the benefit magnitude as moderate, producing an overall grade of B+ (7.1/10). Overshadowed by benzodiazepines and SSRIs but a legitimate non-addictive, non-sedating anxiolytic for chronic GAD.
Is Buspirone safe?
Buspirone has a low risk profile in published human data. Legal status: Rx. This is not medical advice — see the disclaimer.
What is the typical dose for Buspirone?
15-60 mg/day PO divided (2-3x/day)
How does Buspirone work?
Partial agonist at 5-HT1A receptors; weak D2 antagonist; no sedation, no tolerance, no addiction potential unlike benzodiazepines; used for chronic GAD

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.